Stimulating Soluble Guanylyl Cyclase with the Clinical Agonist Riociguat Restrains the Development and Progression of Castration-Resistant Prostate Cancer
Ling Zhang(Third People's Hospital of Yunnan Province), Priyamvada Rai(University of Miami)
Cited by 3
Related Papers
Thioredoxin-1 protects against androgen receptor-induced redox vulnerability in castration-resistant prostate cancer
|Nature Communications|2017|55
The soluble guanylyl cyclase pathway is inhibited to evade androgen deprivation-induced senescence and enable progression to castration resistance
|bioRxiv (Cold Spring Harbor Laboratory)|2023|3